ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 966,74
-0,44%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ardelyx Inc (ARDX)

  7. Ardelyx Inc (ARDX) Actualités

ARDX

Ardelyx (ARDX)

Ardelyx Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARDX
DateHeureSourceTitreSymboleSociété
23/05/202422h58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARDXArdelyx Inc
23/05/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARDXArdelyx Inc
22/05/202414h02GlobeNewswire Inc.Ardelyx to Participate at the 2024 Jefferies Global Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
21/05/202414h02GlobeNewswire Inc.Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in AdultsNASDAQ:ARDXArdelyx Inc
16/05/202414h01GlobeNewswire Inc.Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)NASDAQ:ARDXArdelyx Inc
14/05/202422h02GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement GrantsNASDAQ:ARDXArdelyx Inc
07/05/202414h01GlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week ConferenceNASDAQ:ARDXArdelyx Inc
02/05/202422h02GlobeNewswire Inc.Ardelyx Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
01/05/202414h00GlobeNewswire Inc.Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical MeetingsNASDAQ:ARDXArdelyx Inc
18/04/202414h00GlobeNewswire Inc.Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024NASDAQ:ARDXArdelyx Inc
25/03/202413h00GlobeNewswire Inc.Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and StrategyNASDAQ:ARDXArdelyx Inc
27/02/202414h00GlobeNewswire Inc.Ardelyx to Participate at the Cowen 44th Annual Health Care ConferenceNASDAQ:ARDXArdelyx Inc
22/02/202422h40Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARDXArdelyx Inc
22/02/202422h01GlobeNewswire Inc.Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:ARDXArdelyx Inc
22/02/202412h05IH Market NewsU.S. Futures Surge on Nvidia’s Stellar Performance, Global Markets Respond PositivelyNASDAQ:ARDXArdelyx Inc
13/02/202420h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARDXArdelyx Inc
01/02/202414h00GlobeNewswire Inc.Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:ARDXArdelyx Inc
08/01/202414h00GlobeNewswire Inc.Ardelyx Provides Update on Growing Commercial Momentum and 2024 Strategic PrioritiesNASDAQ:ARDXArdelyx Inc
03/01/202414h03GlobeNewswire Inc.Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8NASDAQ:ARDXArdelyx Inc
21/11/202314h01GlobeNewswire Inc.Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
15/11/202322h02GlobeNewswire Inc.XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric HyperphosphatemiaNASDAQ:ARDXArdelyx Inc
13/11/202322h02GlobeNewswire Inc.Ardelyx Announces Departure of Board MemberNASDAQ:ARDXArdelyx Inc
10/11/202314h05GlobeNewswire Inc.Ardelyx to Participate at the Jefferies London Healthcare ConferenceNASDAQ:ARDXArdelyx Inc
06/11/202314h00GlobeNewswire Inc.Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United StatesNASDAQ:ARDXArdelyx Inc
03/11/202313h00GlobeNewswire Inc.Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023NASDAQ:ARDXArdelyx Inc
31/10/202312h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARDXArdelyx Inc
31/10/202312h00GlobeNewswire Inc.Ardelyx Reports Third Quarter 2023 Financial Results and Updates 2023 U.S. IBSRELA® Net Sales Revenue GuidanceNASDAQ:ARDXArdelyx Inc
23/10/202314h07GlobeNewswire Inc.Ardelyx Shares Positive Data on Symptom Response During Treatment With IBSRELA® (tenapanor) for IBS-C and hosts IBS-C Product Theater at ACG 2023NASDAQ:ARDXArdelyx Inc
18/10/202322h02GlobeNewswire Inc.Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023NASDAQ:ARDXArdelyx Inc
18/10/202321h35AllPennyStocks.comBiotech Finds Mid-Week Success Following FDA AnnouncementNASDAQ:ARDXArdelyx Inc
 Showing the most relevant articles for your search:NASDAQ:ARDX

Dernières Valeurs Consultées

EU
AI
Air Liquide
EU
DG
Vinci
EU
ACA
Credit Agricole
EU
CS
Axa
NASDAQ
MSFT
Microsoft
EU
CAP
Capgemini
COIN
BTCUSD
Bitcoin
NASDAQ
GOOGL
Alphabet
EU
RI
Pernod Ricard
EU
GLE
Societe Generale
NYSE
NKE
Nike
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés